Related Experiment Video
Updated: May 2, 2026
03:42
Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
Published on: September 27, 2024
1.9K
Pancreatic involvement in small cell lung cancer
Ugur Gonlugur1, Arzu Mirici1, Muammer Karaayvaz2
1Department of Chest Diseases, School of Medicine, Canakkale Onsekiz Mart University, 17100 Canakkale, Turkey.
Radiology and Oncology
|March 4, 2014
Summary
Pancreatic metastases from small cell lung cancer are rare but can cause symptoms. Early chemotherapy improves survival, and tissue diagnosis is crucial for differentiating them from primary pancreatic tumors.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Limited data exist on the incidence, clinical presentation, and prognosis of pancreatic metastases in small cell lung cancer (SCLC).
- This review synthesizes available English-language literature on this topic.
Purpose of the Study:
- To review the current literature on pancreatic metastases of SCLC.
- To highlight diagnostic challenges and prognostic factors.
Main Methods:
- Literature review of English-language publications.
- Analysis of reported cases regarding incidence, clinical features, and outcomes.
Main Results:
- Pancreatic metastases from SCLC are often asymptomatic.
- Increased detection rates due to multi-detector computed tomography (CT).
- Complications include acute pancreatitis and obstructive jaundice.
Conclusions:
- Tissue diagnosis is essential to distinguish metastases from primary pancreatic tumors.
- Pancreatic metastases indicate a late stage of SCLC.
- Early chemotherapy offers survival benefits, even with complications like pancreatitis or jaundice.
